No Data
Express News | U.S.-listed Chinese stocks surge at the opening, with Alibaba up over 4%.
Express News | U.S.-listed Chinese stocks surge in overnight trading, with Alibaba up over 4%.
The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
Accelerating recovery? In March, domestic Innovative Drugs investment and financing increased by about 50% year-on-year, and the Hong Kong Stock pharmaceutical Sector collectively surged.
① In March, domestic investment and financing for Innovative Drugs increased by approximately fifty percent year-on-year, how significant is the Bullish impact? ② The Hong Kong stock market's pharmaceutical Sector rose collectively, which stocks are attracting market attention?
Express News | Reported Earlier, HUTCHMED To Present New Data On Savolitinib, Fruquintinib, And Surufatinib At AACR 2025 In Chicago
The Innovative Drugs Concept is generally rising, INNOVENT BIO (01801) increased by 7%. Institutions indicate that the actual geopolitical risks in the Sector are relatively low.
Jinwu Financial News | The Innovative Drugs sector generally rose, with Hutchmed (China) (00013) up by 3.92%. The company will announce data at the American Association for Cancer Research (AACR) 2025 annual meeting. In addition, AKESO (09926) rose by 7.1%, INNOVENT BIO (01801) rose by 7%, SKB BIO-B (06990) rose by 4.76%, KEYMED BIO-B (02162) rose by 3.41%, and 3SBIO (01530) rose by 3.28%. Sinolink's Research Reports stated that the rapidly changing external tariff environment provides the pharmaceutical sector with good anti-risk capabilities and growth potential.
